Global Health Economics & Outcomes Research Services Market to Grow at 13% CAGR Forecast to 2030
- kenashman
- 17 hours ago
- 1 min read
PharmiWeb 27 August 2025
The global health economics and outcomes research services market is expected to grow at a CAGR of ~13% during the forecast period. Increase in R&D spending by the pharmaceutical and biotech companies, growing demand for real-world evidence, rising focus on value-based care models, and increasing awareness of the importance of health economics and outcomes research services are some of the key factors driving the market growth. However, limited access to real-world data and the high cost of research remains major constraints for the health economics and outcomes research services market growth.
Health economics and outcomes research (HEOR) services play a key role in the healthcare industry by helping different stakeholders understand the real value of medical products and treatments. HEOR services include evaluation of the economic value, clinical outcome assessment, and how effective a treatment is, and how it affects patients' daily lives. These insights are especially important today as healthcare systems focus more on improving patient outcomes while also controlling costs.
In healthcare industry that is increasingly shifting toward value-based care and outcome-driven reimbursement models, HEOR has become essential for demonstrating the value proposition of drugs, medical devices, and healthcare services. Governments and insurance providers rely on HEOR evidence to make informed decisions about pricing, reimbursement, and coverage, while pharmaceutical and biotech companies use HEOR data to support market access, regulatory submissions, and health technology assessments (HTAs). With the rising demand for cost-effective and patient-centric care, the HEOR services market is gaining traction globally.
